Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: A Comparative study with donepezil - Vasilopoulou_2021_Br.J.Pharmacol__ |
| Author(s) : Vasilopoulou F , Rodriguez-Arevalo S , Bagan A , Escolano C , Grinan-Ferre C , Pallas M |
| Ref : British Journal of Pharmacology , : , 2021 |
| Abstract : Vasilopoulou_2021_Br.J.Pharmacol__ |
| ESTHER : Vasilopoulou_2021_Br.J.Pharmacol__ |
| PubMedSearch : Vasilopoulou_2021_Br.J.Pharmacol__ |
| PubMedID: 33817786 |
| Title : Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease - Grinan-Ferre_2020_Neurotherapeutics__ |
| Author(s) : Grinan-Ferre C , Codony S , Pujol E , Yang J , Leiva R , Escolano C , Puigoriol-Illamola D , Companys-Alemany J , Corpas R , Sanfeliu C , Perez B , Loza MI , Brea J , Morisseau C , Hammock BD , Vazquez S , Pallas M , Galdeano C |
| Ref : Neurotherapeutics , : , 2020 |
| Abstract : Grinan-Ferre_2020_Neurotherapeutics__ |
| ESTHER : Grinan-Ferre_2020_Neurotherapeutics__ |
| PubMedSearch : Grinan-Ferre_2020_Neurotherapeutics__ |
| PubMedID: 32488482 |